Zoetis (ZTS) Amortization - Intangibles (2012 - 2026)
Zoetis (ZTS) posted quarterly Amortization - Intangibles of $31.0 million for Q1 2026, down 3.12% year-over-year from $32.0 million in Q1 2025, and down 48.33% quarter-over-quarter from $60.0 million in Q4 2025.
Zoetis (ZTS) Amortization - Intangibles (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Amortization - Intangibles for 13 consecutive years, with $31.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortization - Intangibles fell 3.12% year-over-year to $31.0 million; the TTM figure through Mar 2026 stood at $171.0 million (up 18.75% YoY), while the FY2025 annual figure was $157.0 million, down 7.65% from the prior year.
- Amortization - Intangibles declined to $31.0 million in Q1 2026 per ZTS's latest filing, from $60.0 million in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $60.0 million in Q4 2025 and bottomed at $8.0 million in Q4 2023.
- Historically, Amortization - Intangibles has averaged $38.5 million across 5 years, with a median of $37.0 million in 2022.
- Annual changes were most pronounced in 2023 — Amortization - Intangibles sank 82.61% — and 2024, when it jumped 425.0%.
- Zoetis' Amortization - Intangibles stood at $46.0 million in 2022, then tumbled by 82.61% to $8.0 million in 2023, then surged by 425.0% to $42.0 million in 2024, then jumped by 42.86% to $60.0 million in 2025, then plunged by 48.33% to $31.0 million in 2026.
- Business Quant data shows ZTS's Amortization - Intangibles at $31.0 million in Q1 2026, $60.0 million in Q4 2025, and $39.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.00 Mn |
| Mar 31, 2026 | 31.00 Mn |
| Dec 31, 2025 | 60.00 Mn |
| Sep 30, 2025 | 39.00 Mn |
| Jun 30, 2025 | 41.00 Mn |
| Mar 31, 2025 | 32.00 Mn |
| Dec 31, 2024 | 42.00 Mn |
| Sep 30, 2024 | 35.00 Mn |
| Jun 30, 2024 | 35.00 Mn |
| Mar 31, 2024 | 37.00 Mn |
| Dec 31, 2023 | 8.00 Mn |
| Sep 30, 2023 | 38.00 Mn |
| Jun 30, 2023 | 48.00 Mn |
| Mar 31, 2023 | 37.00 Mn |
| Dec 31, 2022 | 46.00 Mn |
| Sep 30, 2022 | 37.00 Mn |
| Jun 30, 2022 | 37.00 Mn |
| Mar 31, 2022 | 52.00 Mn |
| Dec 31, 2021 | 50.00 Mn |
| Sep 30, 2021 | 40.00 Mn |